Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization

Pivotal trials of beta-blockers (BB) and angiotensin converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARB) in acute myocardial infarction (AMI) were largely conducted prior to the widespread adoption of early revascularization. A total of 15,073 patients with AMI who underwent inhosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Hui Wen, Zheng, Huili, Richards, A. Mark, Chen, Ruth W., Sahlen, Anders, Yeo, Khung-Keong, Tan, Jack W., Chua, Terrance, Tan, Huay Cheem, Yeo, Tiong Cheng, Ho, Hee Hwa, Liew, Boon-Wah, Foo, Ling Li, Lee, Chi-Hang, Hausenloy, Derek J., Chan, Mark Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495427/
https://www.ncbi.nlm.nih.gov/pubmed/32938986
http://dx.doi.org/10.1038/s41598-020-72232-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495427/
https://www.ncbi.nlm.nih.gov/pubmed/32938986
http://dx.doi.org/10.1038/s41598-020-72232-y

Ejemplares similares